Jean-Yves Blay, Pr
Centre Léon Bérard, Lyon
2
2
1
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Show-Li Sun, MD
Astex Pharmaceuticals, Inc.
Shared therapeutic areas:
Wu Song, MD
First Affiliated Hospital, Sun Yat-Sen University
Shared therapeutic areas:
Jordan D. Berlin, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
C.M.L. van Herpen, MD, Phd
UMCN st Radboud
Shared therapeutic areas:
Se Hoon Park, MD
Samsung Medical Center, Seoul, Korea
Shared therapeutic areas:
Michael Leahy, MBChB, FRACP, FRCP, FRC Path
Fremantle Hospital
Shared therapeutic areas:
Neeta Somaiah
M.D. Anderson Cancer Center
Shared therapeutic areas:
Ross Andrew Soo, MBBS
National University Hospital, Singapore
Shared therapeutic areas:
John W Glod, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jianxiang Wang, Dr.
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
All 2 trials loaded